Physician profile
Neda Sedora
NPI 1508152729
$3,692.68
in general payments reported to CMS, 2019-2025
7 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $700 · 2021: $448 · 2022: $5.65 · 2023: $461 · 2024: $267 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,346.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,041.44 | 2019-2025 | Benchmark, Red 72 |
| Stryker Corporation | $564.49 | 2020-2025 | Broadway 8, Target |
| Imperative Care, INC | $431.99 | 2023-2025 | Zoom Reperfusion Catheter, Zoom 88 Large Distal Platform Support, Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $368.47 | 2023-2025 | Pipeline, Solitaire X |
| Balt USA, LLC | $165.65 | 2025 | Carrier Delivery Catheter |
| Depuy Synthes Sales INC. | $85.28 | 2023-2024 | Embotrap, Cerepak Uniform, Trufill |
| Microvention, INC. | $35.36 | 2023 | Web Aneurysm Embolization System, Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Sedora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.